Also, TrkB is overexpressed in various cancer types, including prostate cancer [14], multiple myeloma [15], Wilms’ tumor [16], lung cancer [17], pancreatic cancer [18] and neuroblastoma [19], and is associated with poor prognosis [20, 21]. Here, NTRK2 is linked to neuroblastoma.